Bioinformatics Platform Global Market Report 2025

The bioinformatics platform market size has grown strongly in recent years. It will grow from $9.69 billion in 2024 to $10.51 billion in 2025 at a compound annual growth rate (CAGR) of 8.5%. The growth during the historic period can be attributed to a heightened focus on systems biology and integrative omics, increasing collaborations between research institutes and biotech companies, rising awareness of the benefits of bioinformatics, a growing number of bioinformatics-enabled startups, and expanding government initiatives and funding in genomics research.

The bioinformatics platform market size is expected to see strong growth in the next few years. It will grow to $14.35 billion in 2029 at a compound annual growth rate (CAGR) of 8.1%. The growth during the forecast period can be attributed to the increasing demand for personalized medicine, the rising volume of biological and genomic data, growing investments in drug discovery and development, the increasing adoption of cloud-based bioinformatics solutions, and the expanding application of bioinformatics in agriculture and food security. Key trends in the forecast period include advancements in genomics and precision medicine, improvements in AI and machine learning algorithms, integration of cloud-based bioinformatics solutions, multi-omics data analysis, and the adoption of technology in clinical diagnostics and biomarker discovery.

The growing adoption of personalized medicine is expected to drive the growth of the bioinformatics platform market in the coming years. Personalized medicine tailors treatment and prevention strategies based on an individual’s genetic profile, lifestyle, and environmental factors. This approach is gaining momentum due to advances in genomic technologies, which allow for the precise identification of genetic variations associated with diseases, enabling more targeted and effective treatments. The increasing demand for personalized medicine is fueling the need for advanced bioinformatics platforms, as these platforms are crucial for analyzing and interpreting large volumes of genomic and clinical data to develop customized treatment plans. For example, in February 2024, the Personalized Medicine Coalition (PMC), a US-based non-profit organization, reported that the FDA approved 16 new personalized therapies for patients with rare diseases in 2023, a significant increase from the six approvals in 2022. As a result, the rising adoption of personalized medicine is expected to boost the growth of the bioinformatics platform market.

Leading companies in the bioinformatics platform market are developing advanced solutions, such as multiomic data mapping platforms, to provide more accurate insights and a deeper understanding of complex diseases and conditions. These platforms integrate and analyze data from multiple biological layers, including genomics, transcriptomics, proteomics, and metabolomics, to offer a comprehensive view of complex biological processes. For example, in February 2023, BioSkryb Genomics, a US-based biotechnology company, launched the BaseJumper Bioinformatics Platform. This platform enhances the ResolveOME system by simplifying large-scale single-cell informatics. It enables efficient organization and mapping of multiomic data (DNA, RNA, and protein) generated by ResolveOME, streamlining data interpretation. The platform also provides dynamic filtering and a set of visualization tools, enabling researchers across various fields to easily analyze and visualize complex datasets.

In April 2023, Excelra, an India-based informatics company, acquired BISC Global for an undisclosed amount. This acquisition creates a global leader in consulting-driven bioinformatics by combining expertise in artificial intelligence, machine learning, and omics, as well as next-generation sequencing data analysis. The merger aims to accelerate bioinformatics innovation and deliver enhanced benefits to customers from both organizations. BISC Global is a Germany-based provider of bioinformatics platforms.

Major players in the bioinformatics platform market are F. Hoffmann-La Roche Ltd., International Business Machines Corporation, Thermo Fisher Scientific Inc., Eurofins Scientific SE, Dassault Systèmes SE, Agilent Technologies Inc., Illumina Inc., Wuxi NextCODE, PerkinElmer Inc., Bio-Rad Laboratories Inc., Waters Corporation, Bruker Corporation, Partek Incorporated, Qiagen N.V., NeoGenomics Laboratories Inc., Genedata AG, ID Business Solutions, DNAnexus Inc., Sophia Genetics S.A., Accelrys Inc., DNASTAR Inc., Gene Codes Corporation, BGI Group, Fios Genomics Ltd., and Golden Helix Inc.

North America was the largest region in the bioinformatics platform market in 2024. The regions covered in bioinformatics platform report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the bioinformatics platform market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

A bioinformatics platform is a comprehensive software system that combines various tools, algorithms, and databases to support the analysis, interpretation, and management of biological data. These platforms often enable collaborative research by integrating multidisciplinary knowledge and resources to advance progress in healthcare, drug development, and personalized medicine.

Key bioinformatics platforms include sequence analysis platforms, sequence alignment platforms, sequence manipulation platforms, structural and functional analysis platforms, and more. A sequence analysis platform is a software or toolset designed to process, analyze, and interpret biological sequences, such as DNA, RNA, or protein data. It is used in genomics, proteomics, drug discovery, personalized medicine, and other fields by a range of end-users, including pharmaceutical and biotechnology companies, academic and research institutions, healthcare providers, and others.

The bioinformatics platform market research report is one of a series of new reports that provides bioinformatics platform market statistics, including bioinformatics platform industry global market size, regional shares, competitors with a bioinformatics platform market share, detailed bioinformatics platform market segments, market trends and opportunities, and any further data you may need to thrive in the bioinformatics platform industry. This bioinformatics platform market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The bioinformatics platform market consists of revenues earned by entities by providing services such as transcriptomics services, data integration and visualization, custom pipeline development, and training and consulting services. The market value includes the value of related goods sold by the service provider or included within the service offering. The bioinformatics platform market also includes sales of biological databases, cloud computing platforms, genome annotation tools, and clinical interpretation tools. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.